Aetna Inc. (AET) Shares Bought by Psagot Investment House Ltd.
Psagot Investment House Ltd. raised its position in shares of Aetna Inc. (NYSE:AET) by 1.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,035 shares of the company’s stock after purchasing an additional 549 shares during the period. Psagot Investment House Ltd.’s holdings in Aetna were worth $5,623,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. State of Tennessee Treasury Department raised its position in Aetna by 26.3% during the second quarter. State of Tennessee Treasury Department now owns 557,814 shares of the company’s stock valued at $84,692,000 after purchasing an additional 116,280 shares in the last quarter. Pictet & Cie Europe SA acquired a new position in shares of Aetna during the second quarter worth $2,269,000. Banque Pictet & Cie SA acquired a new position in shares of Aetna during the second quarter worth $10,567,000. NBT Bank N A NY acquired a new position in shares of Aetna during the second quarter worth $215,000. Finally, Cambridge Investment Research Advisors Inc. increased its holdings in shares of Aetna by 4.5% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 36,731 shares of the company’s stock worth $5,577,000 after buying an additional 1,590 shares in the last quarter. Institutional investors and hedge funds own 89.52% of the company’s stock.
Aetna Inc. (NYSE:AET) traded up 0.588% during mid-day trading on Wednesday, reaching $156.515. The company had a trading volume of 723,893 shares. The firm has a 50-day moving average price of $158.39 and a 200 day moving average price of $148.58. The firm has a market capitalization of $51.92 billion, a price-to-earnings ratio of 34.704 and a beta of 0.53. Aetna Inc. has a 12-month low of $104.59 and a 12-month high of $164.52.
Aetna (NYSE:AET) last released its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The firm had revenue of $15.52 billion for the quarter, compared to analysts’ expectations of $15.34 billion. During the same quarter in the previous year, the company earned $2.21 earnings per share. The company’s revenue for the quarter was down 2.7% compared to the same quarter last year. Analysts expect that Aetna Inc. will post $9.55 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Thursday, October 12th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.28%. The ex-dividend date of this dividend is Wednesday, October 11th. Aetna’s payout ratio is 43.67%.
Several brokerages have recently issued reports on AET. Zacks Investment Research downgraded shares of Aetna from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. Cantor Fitzgerald reiterated an “overweight” rating and set a $175.00 price target (up from $150.00) on shares of Aetna in a report on Wednesday, August 9th. Jefferies Group LLC reiterated a “hold” rating and set a $163.00 price target (up from $157.00) on shares of Aetna in a report on Friday, August 4th. Deutsche Bank AG upped their price target on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a report on Monday, August 7th. Finally, Royal Bank Of Canada upped their price target on shares of Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a report on Friday, August 4th. Eight research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Aetna currently has an average rating of “Buy” and an average target price of $160.77.
In other Aetna news, EVP Margaret M. Mccarthy sold 10,288 shares of the business’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $162.85, for a total value of $1,675,400.80. Following the transaction, the executive vice president now owns 33,563 shares in the company, valued at $5,465,734.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the transaction, the president now owns 64,261 shares in the company, valued at approximately $10,404,498.51. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.